NCT00378378View on ClinicalTrials.gov

Study of Nasonex® for the Treatment of Nasal Polyps in Pediatric Subjects Between Ages of 6 and Less Than 18 Years Old (P04292)

PHASE3CompletedINTERVENTIONAL

Enrollment

127

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions

Nasal Polyps

Interventions

DRUG

Mometasone Furoate Nasal Spray (MFNS)

100 mcg nasal spray

DRUG

Placebo nasal spray

One spray of placebo nasal spray in each nostril once daily for 4 months.

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00378378 - Study of Nasonex® for the Treatment of Nasal Polyps in Pediatric Subjects Between Ages of 6 and Less Than 18 Years Old (P04292) | Biotech Hunter | Biotech Hunter